Todd Romigh

1.1k total citations
27 papers, 716 citations indexed

About

Todd Romigh is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Todd Romigh has authored 27 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Genetics. Recurrent topics in Todd Romigh's work include PI3K/AKT/mTOR signaling in cancer (17 papers), CRISPR and Genetic Engineering (4 papers) and Epigenetics and DNA Methylation (3 papers). Todd Romigh is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (17 papers), CRISPR and Genetic Engineering (4 papers) and Epigenetics and DNA Methylation (3 papers). Todd Romigh collaborates with scholars based in United States, India and Australia. Todd Romigh's co-authors include Charis Eng, Xin He, Robert H. Silverman, Warren D.W. Heston, Mohammed S. Orloff, Thomas Frazier, Qi Yu, Kristi L. Bennett, Xin He and Kristin Waite and has published in prestigious journals such as JAMA, Gastroenterology and PLoS ONE.

In The Last Decade

Todd Romigh

26 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Todd Romigh United States 16 479 125 124 119 114 27 716
Celina García-García Italy 8 510 1.1× 123 1.0× 70 0.6× 107 0.9× 60 0.5× 13 690
Angelo Notarangelo Italy 13 449 0.9× 71 0.6× 148 1.2× 70 0.6× 42 0.4× 29 806
Tomoko Tsuruta Japan 14 343 0.7× 195 1.6× 50 0.4× 75 0.6× 79 0.7× 26 925
Laura Riva Italy 14 789 1.6× 95 0.8× 108 0.9× 188 1.6× 69 0.6× 33 1.0k
Pai‐Mei Lin Taiwan 19 485 1.0× 170 1.4× 50 0.4× 193 1.6× 56 0.5× 33 1.0k
Zhenghuan Fang South Korea 15 262 0.5× 165 1.3× 54 0.4× 103 0.9× 45 0.4× 33 556
Ji Yeon Hong United States 10 540 1.1× 110 0.9× 117 0.9× 61 0.5× 42 0.4× 11 822
Seungyeul Yoo United States 14 587 1.2× 110 0.9× 101 0.8× 184 1.5× 123 1.1× 26 944
Eric Bareke Canada 14 403 0.8× 57 0.5× 167 1.3× 129 1.1× 61 0.5× 42 639
David C. Bedford United States 10 464 1.0× 124 1.0× 102 0.8× 47 0.4× 49 0.4× 12 774

Countries citing papers authored by Todd Romigh

Since Specialization
Citations

This map shows the geographic impact of Todd Romigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Romigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Romigh more than expected).

Fields of papers citing papers by Todd Romigh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Romigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Romigh. The network helps show where Todd Romigh may publish in the future.

Co-authorship network of co-authors of Todd Romigh

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Romigh. A scholar is included among the top collaborators of Todd Romigh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Romigh. Todd Romigh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pobbati, Ajaybabu V., Todd Romigh, Bin Zhao, et al.. (2024). CDK9 Inhibition by Dinaciclib Is a Therapeutic Vulnerability in Epithelioid Hemangioendothelioma. Clinical Cancer Research. 30(18). 4179–4189. 4 indexed citations
2.
Hooper, Alice, Jonathan D. Macdonald, Sang Hoon Han, et al.. (2023). SARS-CoV-2 3CL-protease inhibitors derived from ML300: investigation of P1 and replacements of the 1,2,3-benzotriazole. Medicinal Chemistry Research. 32(7). 1383–1390.
3.
Chelakkot, Vipin Shankar, Todd Romigh, Lin Li, et al.. (2023). MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression. npj Precision Oncology. 7(1). 85–85. 10 indexed citations
4.
Romigh, Todd, Stetson Thacker, Ata Abbas, et al.. (2021). Redefining the PTEN promoter: identification of novel upstream transcription start regions. Human Molecular Genetics. 30(22). 2135–2148. 8 indexed citations
5.
Ni, Ying, Benjamin Fletcher, Todd Romigh, et al.. (2016). Germline compound heterozygous poly-glutamine deletion inUSF3may be involved in predisposition to heritable and sporadic epithelial thyroid carcinoma. Human Molecular Genetics. 26(2). ddw382–ddw382. 13 indexed citations
6.
He, Xin, Stetson Thacker, Todd Romigh, et al.. (2015). Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traits. Molecular Autism. 6(1). 14–14. 26 indexed citations
7.
Tilot, Amanda K., Gürkan Bebek, Feizollah Niazi, et al.. (2015). Neural transcriptome of constitutional Pten dysfunction in mice and its relevance to human idiopathic autism spectrum disorder. Molecular Psychiatry. 21(1). 118–125. 46 indexed citations
9.
Tilot, Amanda K., Qi Yu, Todd Romigh, et al.. (2014). Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production. Human Molecular Genetics. 23(12). 3212–3227. 56 indexed citations
10.
Wang, Yu, Qi Yu, Xin He, et al.. (2013). Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation. Molecular Cancer Therapeutics. 13(2). 517–527. 26 indexed citations
11.
He, Xin, et al.. (2013). Cowden Syndrome-Related Mutations in PTEN Associate with Enhanced Proteasome Activity. Cancer Research. 73(10). 3029–3040. 20 indexed citations
12.
He, Xin, Motoyasu Saji, Todd Romigh, et al.. (2012). PTEN Lipid Phosphatase Activity and Proper Subcellular Localization Are Necessary and Sufficient for Down-Regulating AKT Phosphorylation in the Nucleus in Cowden Syndrome. The Journal of Clinical Endocrinology & Metabolism. 97(11). E2179–E2187. 16 indexed citations
13.
Orloff, Mohammed S., Charissa Peterson, Xin He, et al.. (2011). Germline Mutations in MSR1, ASCC1, and CTHRC1 in Patients With Barrett Esophagus and Esophageal Adenocarcinoma. JAMA. 306(4). 410–410. 79 indexed citations
14.
He, Xin, Ying Ni, Yu Wang, Todd Romigh, & Charis Eng. (2010). Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53. Human Molecular Genetics. 20(1). 80–89. 29 indexed citations
15.
Wang, Yu, Todd Romigh, Xin He, et al.. (2010). Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines. Human Molecular Genetics. 19(22). 4319–4329. 89 indexed citations
16.
Bennett, Kristi L., Todd Romigh, & Charis Eng. (2009). Disruption of Transforming Growth Factor-β Signaling by Five Frequently Methylated Genes Leads to Head and Neck Squamous Cell Carcinoma Pathogenesis. Cancer Research. 69(24). 9301–9305. 26 indexed citations
17.
Lobo, Glenn P., Kristin Waite, Sarah M. Planchon, et al.. (2009). Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function. Human Molecular Genetics. 18(15). 2851–2862. 38 indexed citations
18.
Jacob, Avi, Todd Romigh, Kristin Waite, & Charis Eng. (2009). Nuclear PTEN levels and G2 progression in melanoma cells. Melanoma Research. 19(4). 203–210. 13 indexed citations
19.
Lobo, Glenn P., Kristin Waite, Sarah M. Planchon, et al.. (2008). ATP modulates PTEN subcellular localization in multiple cancer cell lines. Human Molecular Genetics. 17(18). 2877–2885. 28 indexed citations
20.
Bennett, Kristi L., Todd Romigh, Khelifa Arab, et al.. (2008). Activator protein 2 alpha (AP2α) suppresses 42 kDa C/CAAT enhancer binding protein α (p42C/EBPα) in head and neck squamous cell carcinoma. International Journal of Cancer. 124(6). 1285–1292. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026